Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Huntly, Brian J P  [Clear All Filters]
Journal Article
Fong CYew, Gilan O, Lam EYN, Rubin AF, Ftouni S, Tyler D, Stanley K, Sinha D, Yeh P, Morison J, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015.
Gallipoli P, Giotopoulos G, Huntly BJP. Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia. Ther Adv Hematol. 2015;6(3):103-119.
Gilan O, Lam EYN, Becher I, Lugo D, Cannizzaro E, Joberty G, Ward A, Wiese M, Fong CYew, Ftouni S, et al. Functional interdependence of BRD4 and DOT1L in MLL leukemia. Nat Struct Mol Biol. 2016.
Caeser R, Di Re M, Krupka JA, Gao J, Lara-Chica M, Dias JML, Cooke SL, Fenner R, Usheva Z, Runge HFP, et al. Genetic modification of primary human B cells to model high-grade lymphoma. Nat Commun. 2019;10(1):4543.
Lara-Astiaso D, Goñi-Salaverri A, Mendieta-Esteban J, Narayan N, Del Valle C, Gross T, Giotopoulos G, Beinortas T, Navarro-Alonso M, Aguado-Alvaro LPilar, et al. In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis. Nat Genet. 2023.
Giotopoulos G, Huntly BJP. Intratumoral Heterogeneity: Tools to Understand and Exploit Clone Wars in AML. Cancer Cell. 2018;34(4):533-535.
Yun H, Vohra S, Lara-Astiaso D, Huntly BJP. Multiomics data integration to reveal chromatin remodeling and reorganization induced by gene mutational synergy. STAR Protoc. 2022;3(4):101770.
Isobe T, Kucinski I, Barile M, Wang X, Hannah R, Bastos HP, Chabra S, Vijayabaskar MS, Sturgess KHM, Williams MJ, et al. Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes. Cell Genom. 2023;3(12):100426.
Narayan N, Huntly BJP. Targeting AML at the intersection of epigenetics and signaling. Sci Signal. 2022;15(730):eabo0059.